scispace - formally typeset
P

Paolo Prandoni

Researcher at University of Padua

Publications -  578
Citations -  54928

Paolo Prandoni is an academic researcher from University of Padua. The author has contributed to research in topics: Thrombosis & Venous thrombosis. The author has an hindex of 99, co-authored 552 publications receiving 49073 citations. Previous affiliations of Paolo Prandoni include University of Amsterdam & University of Greifswald.

Papers
More filters
Journal Article

Collaborative overview of randomized trials of antiplatelet therapy .1. prevention of death, myocardial-infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

R Altman, +418 more
- 08 Jan 1994 - 
TL;DR: There was no appreciable evidence that either a higher aspirin dose or any other antiplatelet regimen was more effective than medium dose aspirin in preventing vascular events, so in each of the four main high risk categories overall mortality was significantly reduced.
Journal ArticleDOI

The long-term clinical course of acute deep venous thrombosis.

TL;DR: The clinical course of a first episode of symptomatic deep venous thrombosis in a large consecutive series of patients who had long-term follow-up was assessed and the potential risk factors for these three outcomes were evaluated.
Journal ArticleDOI

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

TL;DR: Possibility for improvement using the current paradigms of anticoagulation seem limited and new treatment strategies should be developed, as cancer patients with venous thrombosis are more likely to develop recurrent thromboembolic complications and major bleeding during anticoaggerant treatment than those without malignancy.